AccuLabs Diagnostics sold from administration, saving 32 Jobs

AccuLabs Diagnostics UK Limited has been sold out of administration to its incumbent directors, preserving all 32 jobs at the North East medical testing business.

Andrew Little and Gillian Sayburn of BTG Begbies Traynor were appointed joint administrators on 16 June 2026 and completed the sale following a marketing process that generated four bids.

The Wynyard-based company had been marketed for several weeks before the appointment. BTG said the directors submitted the successful offer, allowing the business to continue under its existing management team.

Established in 2010, AccuLabs provides medical testing and diagnostic services to healthcare-sector clients. Its contract pipeline includes testing work associated with weight-loss medication.

The company encountered financial pressure after several significant contracts took longer than expected to begin, resulting in continuing trading losses. The directors provided financial support during that period, but the company fell behind on payments to HM Revenue & Customs.

AccuLabs subsequently proposed a company voluntary arrangement, but HMRC rejected the proposal, prompting the directors to seek the appointment of administrators.

The administrators said the transaction is expected to produce a substantial return for unsecured creditors, although the purchase price and projected dividend have not been disclosed.

Little said the interest generated during the marketing process demonstrated the underlying strength of the business and that the sale provided a positive result for employees and creditors.